RESÚMENES AGOSTO 2009

.

Addictive Disorders

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana

 

3 - Attenuation of cue-induced smoking urges and brain reward activity in smokers treated successfully with bupropion

A Weinstein, J Greif, Z Yemini, H Lerman, A Weizman, and E Even-Sapir

Journal of Psychopharmacology 2009, First published on July 31, 2009


5 - Randomized, Double-Blind, Placebo-Controlled Trial of Vigabatrin for the Treatment of Cocaine Dependence in Mexican Parolees

Jonathan D. Brodie, Brady G. Case, Emilia Figueroa, Stephen L. Dewey, James A. Robinson, Joseph A. Wanderling, and Eugene M. Laska

Am J Psychiatry Published August 3, 2009

3 - A safety and tolerability laboratory study of the combination of aripiprazole and topiramate in volunteers who drink alcohol

George A. Kenna, Lorenzo Leggio, Robert M. Swift

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 6, Pages 465 - 472

 

3 - The effects of energy drinks alone and with alcohol on neuropsychological functioning

Kim Curry, Michael J. Stasio

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 6, Pages 473 - 481

 

3 - Role for GABA agonists in the nucleus accumbens in regulating morphine self-administration

Seong Shoon Yoon, Jung-Ae Kim, Bong Hyo Lee, Kwang-Ho Choi, Insop Shim, Seong Hun Choi, Meeyul Hwang and Chae Ha Yang

Neuroscience Letters. Volume 462, Issue 3, 25 September 2009, Pages 289-293

 

3! - Timing of first alcohol use and alcohol dependence: evidence of common genetic influences

Carolyn E. Sartor, Michael T. Lynskey, Kathleen K. Bucholz, Pamela A. F. Madden , Nicholas G. Martin & Andrew C. Heath

Addiction. Volume 104 Issue 9, Pages 1512 - 1518

 

5 - Smoking cessation during alcohol treatment: a randomized trial of combination nicotine patch plus nicotine gum

Ned L. Cooney, Judith L. Cooney, Bridget L. Perry, Michael Carbone, Emily H. Cohen, Howard R. Steinberg , David T. Pilkey, Kevin Sevarino, Cheryl A. Oncken & Mark D. Litt

Addiction. Volume 104 Issue 9, Pages 1588 - 1596

 

5 - A double-blind, randomized, parallel group study to compare the efficacy, safety and tolerability of slow-release oral morphine versus methadone in opioid-dependent in-patients willing to undergo detoxification

Ekkehard Madlung-Kratzer, Berhard Spitzer, Renate Brosch, Dirk Dunkel & Christian Haring

Addiction. Volume 104 Issue 9, Pages 1549 - 1557

 

5 - Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment

Peter Hajek, Philip Tønnesen, Carmen Arteaga, Cristina Russ & Serena Tonstad

Addiction. Volume 104 Issue 9, Pages 1597 - 1602

 

GRATIS 3! - Marijuana craving in the brain

Francesca M. Filbey, Joseph P. Schacht, Ursula S. Myers, Robert S. Chavez and Kent E. Hutchison

PNAS August 4, 2009 vol. 106 no. 31 13016-13021

 

3! - Modafinil reinstates a cocaine conditioned place preference following extinction in rats

Rick E. Bernardi, Jason R. Lewis, K. Matthew Lattal and S. Paul Berger

Behavioural Brain Research. Volume 204, Issue 1, 1 December 2009, Pages 250-253

 

3 - Effects of Ginkgo biloba extract on the pharmacokinetics of bupropion in healthy volunteers

He-Ping Lei, Wei Ji, Jian Lin, Hao Chen, Zhi-Rong Tan, Dong-Li Hu, Li-Juan Liu & Hong-Hao Zhou

British Journal of Clinical Pharmacology. Volume 68 Issue 2, Pages 201 - 206

 

3! - Transplacental transfer and metabolism of bupropion

Angela D. Earhart;  Svetlana Patrikeeva;  Xiaoming Wang;  Doaa Reda Abdelrahman;  Gary D. V. Hankins;  Mahmoud S. Ahmed; Tatiana Nanovskaya

The Journal of Maternal-Fetal & Neonatal Medicine. First Published on: 31 July 2009

 

3 - Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users

K Allott, BJ Canny, JH Broadbear, NK Stepto, B Murphy, J Redman

Journal of Psychopharmacology, Vol. 23, No. 7, 759-774 (2009)

3 - Are adolescents more vulnerable to drug addiction than adults? Evidence from animal models

Nicole L. Schramm-Sapyta, Q. David Walker, Joseph M. Caster, Edward D. Levin and Cynthia M. Kuhn

Psychopharmacology. Volume 206, Number 1 / September, 2009: 1-21Review

 

3! - Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis

Paolo Boffetta, Kurt Straif

BMJ 2009;339:b3060

 

3 - Buprenorphine Medication Versus Voucher Contingencies in Promoting Abstinence From Opioids and Cocaine

Mohit P. Chopra, Reid D. Landes, Kirstin M. Gatchalian, Lisa C. Jackson, August R. Buchhalter, Maxine L. Stitzer, Lisa A. Marsch and Warren K. Bickel

Experimental and Clinical Psychopharmacology. Volume 17, Issue 4, August 2009, Pages 226-236

 
3 - The clinical efficacy and abuse potential of combination buprenorphine–naloxone in the treatment of opioid dependence

Kristie Mammen & James Bell

Expert Opinion on Pharmacotherapy. Posted online on 27 Aug 2009

 

GRATIS 3 - Biologic Commonalities between Mental Illness and Addiction

Karen J. Hartwell, Bryan K. Tolliver, and Kathleen T. Brady

Primary Psychiatry. 2009;16(8):33-39

 

GRATIS 3 - Genetic Influences on Addiction

Alexis C. Edwards, Dace S. Svikis, Roy W. Pickens, and Danielle M. Dick

Primary Psychiatry. 2009;16(8):40-46

 

GRATIS 3! - Biologic Treatments for Drug and Alcohol Dependence

Kyle M. Kampman

Primary Psychiatry. 2009;16(8):47-52

 

GRATIS 3 - The Neurobiological Development of Addiction. An Overview

Aviel Goodman

Psychiatric Times. 2009; Vol. 26 No. 9

 

 


.

Regresar a RESÚMENES AGOSTO 2009

© 1999-2009 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.